Dr. Mica Yael Bergman, MD, PhD

Dr. Bergman practices at Foothill Surgery Center at Sansum Clinic in Santa Barbara, California.

Dr. Bergman's NPI, 1912268996, was assigned on June 6, 2012. Dr. Bergman graduated from Vanderbilt University School Of Medicine in 2012. Dr. Bergman's California license number on file is A131235.

Dr. Bergman's primary practice is Foothill Surgery Center at Sansum Clinic, at 4151 Foothill Road, Santa Barbara, CA 93110. The practice phone is (805) 681-1760.

Dr. Bergman's primary practice is Foothill Surgery Center at Sansum Clinic in Santa Barbara, California. The medical group on file is Sansum Clinic. Dmand AI also links Dr. Bergman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Bergman's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Bergman is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Bergman has a license on file in California.

Dmand AI lists conjunctivitis, eye infection or inflammation, eyelid inflammation, inflammation of iris and vision problems among the conditions Dr. Bergman treats.

CMS data shows 2,256 Medicare services from Dr. Bergman across 21 procedure codes in 2024, for 759 Medicare patients. Medicare paid $286,627 for them.

CMS counts 759 Medicare patients who saw Dr. Bergman in 2024. The largest group is 65 to 74, with 330 patients. 75% of them have high cholesterol, and 58% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bergman's median patient age at 74, with 64% women.

In 2024, Dr. Bergman wrote 1,103 Medicare Part D claims for 592 patients. 45% of them were for generic drugs. CMS names the drug for 1,029 of them, across 6 drugs with 11 or more claims each, at $13,932 in total drug cost. In 2023, CMS named 937 claims across 6 drugs.

Dr. Bergman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of melanoma (skin cancer) excision by Dr. Bergman, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Bergman, published from 2005 to 2018. 2010 was the busiest year, with 2. The most frequent topics are Hippocampus, Proto-Oncogene Proteins c-met and Autistic Disorder. Dr. Bergman's most frequent co-authors are Michael J. Friez, PhD, FACMG, Daniel Hal Geschwind, MD and David B. Samimi, MD.

CMS Open Payments shows 40 general payments to Dr. Bergman from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $759.

Dr. Bergman graduated from Vanderbilt University School Of Medicine in 2012.

Dr. Bergman is in network with 18 carriers, including Aetna, Elevance and HCSC. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.